Abstract
The therapy of hypertension has evolved over the past 50 years from the short-term care of a small number of hospitalized patients with severely elevated blood pressure and organ damage to a major community health problem involving a substantial proportion of the population with mild to moderate hypertension. In the beginning, severe side effects and toxicity of antihypertensive agents were accepted by patients and doctors as the price that had to be paid for this lifesaving therapy. The results of recent therapeutic trials show the benefits of antihypertensive treatment for mild to moderate hypertension. This has changed the attitudes towards treatment. The aim of modern antihypertensive therapy is the reduction of the risk of cardiovascular disease. The management of hypertensive patients therefore has to include the minimization of other controllable risk factors such as diabetes, hypercholesterolemia, alcohol, and cigarette smoking. Blood pressure lowering can be achieved not only by pharmacological substances but also by non-drug methods, e. g., reduction of sodium intake, reduction of body weight, reduction of alcohol intake, increased physical activity, and meditation. These methods are part of an antihypertensive strategy with different priorities in the European countries.
Professor Shkhvatsabaya died October 11th, 1988.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
References
Antonaccio MJ (ed) (1977) Cardiovascular pharmacology. Raven, New York
Birkenhäger WH, Reid JL (1984) Clinical pharmacology of antihypertensive drugs. In: Doyle AE (ed) Handbook of hypertension. Elsevier, Amsterdam
Bundesverband der Pharmazeutischen Industrie (1986) Basisdaten des Gesundheitwesens 1985/86. Bundesverband der Pharmazeutischen Industrie, Frankfurt
Davies DS, Reid JL (eds) (1975) Central action of drugs in blood pressure regulation. Pitman, London
Doyle AE, Beam AG (eds) (1984) Hypertension and the angiotensin system. Raven,New York
Drayer JIM, Lowenthal DT, Weber MA (eds) (1987) Drug therapy in hypertension. Dekker, New York
Ganten D, Ritz E (eds) (1985) Lehrbuch der Hypertonie. Schattauer, Stuttgart
Genest J, Kuchel O, Hamet P, Cantin M (eds) (1983) Hypertension. McGraw-Hill, New York
Gessler U (ed) (1978) Differentialdiagnose und Therapie der Hypertonie. Aesopus, Lugano
Kaufmann W, Bonner G, Lang R, Meurer KA (eds) (1986) Primary hypertension. Springer, Berlin Heidelberg New york
Kobinger W, Ahlquist RP (eds) (1984) Alpha and beta adrenoceptors and the cardiovascular system. Excerpta Medica, Amsterdam
McMahon FG (ed) (1978) Management of essential hypertension. Futura, New York
Rosenthal J (ed) (1986) Arterielle Hypertonie. Springer, Berlin Heidelberg New York
Stumpe KO (ed) (1983) Therapie mit Antihypertensiva. Springer, Berlin Heidelberg New York
References
Baksaas I (1984) Patterns in drug utilization—national and international aspects: Antihypertensive drugs. Acta Med Scand [Suppl] 683: 59–66
Griffiths K, McDevitt DG, Andrew M, Baksaas I, Helgeland A, Jervell J, Lunde PKM, et al. (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden. II. Hypertension. Eur J Clin Pharmacol 30: 521–525
Nordic Council on Medicines (1979) Nordic statistics on medicines 1975–1977. Nordic Council on Medicines, Helsinki
Nordic Council on Medicines (1982) Nordic statistics on medicines 1978–1980. Nordic Council on Medicines, Uppsala
Nordic Council on Medicines (1986) Nordic statistics on medicines 1981–1983. Nordic Council on Medicines, Uppsala
Swedish Statistics on Medicines (1986) Diagnosis and therapy survey. Apoteksbolaget, Stockholm
Waaler HT, Hjort PF (1982) The consumption of blood pressure lowering drugs in the Nordic countries. In: Nordic Council on Medicines (ed) Nordic statistics on medicines 1978–1980. Nordic Council on Medicines, Uppsala, pp 195–215 (NLN publication no 8 )
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 5: 335–371
References
Barlow RB, Ing HR (1948) Curare-like action of polymethylene bisquarternary ammonium salts. Nature 161: 718
Beilin LJ (1988) Epitaph to essential hypertension: a preventable disorder of known aetiology? J Hypertens 6: 85–94
Black J (1988) Beta-blockers in clinical practice. Livingstone, Edinburgh, pp v–vii
Bright R (1827) Reports of medical cases, selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. Longman, London
Bright R (1836) Tabular view of the morbid appearances in 100 cases connected with albuminous urine. With observations. Guy’s Hosp Rep 1: 380–392
Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low-dose treatment. Br Med J 289: 410–412
Cranston WI, Juel-Jensen BE, Semmence AM, Handfield-Jones RPC, Forbes JA, Mutch LMM (1963) Effects of oral diuretics on raised arterial pressure. Lancet 2:966–970 Cruickshank JM, Prichard BNC (1988) Beta-blockers in clinical practice. Livingstone, Edinburgh, pp 3–8
Dollery C (1987) Jubilee editorial: hypertension. Br Heart J 58: 179–184
Leishman A WD (1959) Hypertension treated and untreated: a study of 400 cases. Br Med J 1: 1361–1368
McAreavey D, Ramsay LE, Latham L, McLaren AD, Lorimer AR, Reid JL, Robertson JIS, et al. (1984) “Third Drug” trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta-blocker plus thiazide diuretic. Br Med J 288:106–111
McMichael J (1952) The management of hypertension. Br Med J 1: 933–938
Medical Research Council Working Party (1981) Adverse reactions to bendrofluazide and propranolol following treatment of mild hypertension. Lancet 2: 539–543
Medical Research Council Working Party (1983) Ventricular extrasystoles during thiazide treatment: substudy of the MRC Mild Hypertension Trial. Br Med J 287: 1249–1253
Medical Research Council Working Party (1985) MRC Trial of Treatment of Mild
Hypertension: principal results. Br Med J 291:97–104
Paton WD, Zaimis E (1948) Curare-like action of polymethylene bis-quarternary salts. Nature 161: 718
Perry HM, Schroeder HA (1954) A syndrome simulating collagen disease caused by 1-hydrazino-phthaline (apresoline). JAMA 154: 670–673.
Pickering GW (1968) High blood pressure, 2nd edn. J amp; A Churchill, London
Piatt R (1954) Hypertensive retinopathy and its medical treatment. Q J Med 23: 441–449
Piatt R, Sears HTN (1956) Reserpine in severe hypertension. Lancet 1: 401–403
Prichard BN (1964) Hypotensive action of pronethalol. Br Med J 1: 1227–1228
References
Ramsay LE (1985) Mild hypertension: treat patients, not populations. J Hypertens 3: 449–455
Robertson JIS (1987) The large studies in hypertension: what have they shown? Br J Clin Pharmacol 24:3–14 S
Robertson JIS, Ball SG (1989) Hypertension. In: Julian DG, Poole-Wilson PW, Fox K, Camm AJ, Hall R (eds) Diseases of the heart. Baillière Tindall, London 1227–1292
Rosenheim ML (1954) The treatment of severe hypertension. Br Med J 2: 1181–1193
Smirk FH (1957) High arterial pressure. Blackwell, Oxford, pp 532–535
Swales JD (1985) Piatt versus Pickering: an episode in recent medical history. Keynes/ British Medical Association, London
Swales JD (1988) Non-pharmacological antihypertensive therapy. Eur Heart J [Suppl Gl 9: 45–52
Swales JD, Ramsay LE, Coope J, Pocock S, Robertson JIS, Shafer J, Sever P (1989) Treatment of mild hypertension: Recommendations of the British Hypertension Society. Br Med J 298: 694–698
Weber MA (1987) Automatic blood pressure recorders and 24 hour monitoring. Curr Opin Cardiol 2: 748–757
Alderman MH (1980) Mild hypertension: new light on an old clinical controversy. Am J Med 69: 653–655
Anonymous (1974) Drugs for hypertension. Med Lett 16: 65–68
Anonymous (1977) Drugs for hypertension. Med Lett 19: 21–24
Anonymous (1984) Drugs for hypertension. Med Lett 26: 107–112
Anonymous (1987) Drugs for hypertension. Med Lett 29: 1–6
Cloher TP, Whelton PK (1986) Physician approach to the recognition and initial management of hypertension: results of a statewide survey of Maryland physicians. Arch Intern Med 146: 529–533
Davidson RA, Meuleman JR (1986) Initial treatment of hypertension: a questionnaire survey. J Clin Hypertens 4: 339–345
Dustan HP (1987) Rational therapies for hypertension: is step 1 of stepped care archaic? Circulation 75: 96–100
Dzau VJ (1987) Evolution of the clinical management of hypertension: emerging role of “specific” vasodilators as initial therapy. Am J Med [Suppl 1A] 82: 36–43
Freis ED (1982) Should mild hypertension be treated? N Engl J Med 307: 306–309
Graves J (1987) Frequent-flyer programs for drug prescribing. N Engl J Med 317: 252
Guttmacher S, Teitelman M, Chapin G, Garbowski G, Schnall P (1981) Ethics and preventive medicine: the case of borderline hypertension. Hastings Center Rep 11: 12–20
Hart JT (1983) The practitioner’s view. In: Gross F, Strasser T (eds) Mild hypertension: recent advances. Raven, New York, pp 365–374
IMS America (1986) National disease and therapeutic index. Ambler, Pennsylvania
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1977) Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 237: 255–261
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1980) The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 140: 1280–1285
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984) The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 144: 1045–1057
Joint National Committee on Detection, Evaluation, and Treatment of High Blood
Pressure (1988) The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 148: 1023–1038
Kaplan NM (1981) Whom to treat: the dilemma of mild hypertension. Am Heart J 101: 867–870
Kaplan NM (1986a) Treatment of hypertension: drug therapy. In: Kaplan NM (ed) Clinical hypertension, 4th edn. Williams and Wilkin, Baltimore, pp 180–272
Kaplan NM (1986b) Hypertension in the population at large. In: Kaplan NM (ed) Clinical hypertension, 4th edn. Williams and Wilkins, Baltimore, pp 1–28
Kaplan NM (1987) Misdiagnosis of systemic hypertension and recommendations for improvement. Am J Cardiol 80: 1383–1386
Koch H (1987) Highlights of drug utilization. In: National Center for Health Statistics (ed) Office Practice National Ambulatory Medical Care Survey, 1985. Public Health Service, Hyattville (Vital and Health Statistic no 134; DHHS publ no (PHS) 87–1250 )
Kosecoff J, Fink A, Brook RH, et al. (1985) General medical care and the education of internists in university hospitals: an evaluation of the Teaching Hospital General Medicine Group Practice Program. Ann Intern Med 102: 250–257
Krakoff LR, Phillips RA, Eison HB (1987) New directions for hypertenion therapy. Compr Ther 13: 61–68
Laragh JH (1973) Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 55: 261–274
Rowland M, Roberts J (1982) Advance data from Vital and Health Statistics no 84. Public Health Services, Washington
WHO Drug Utilization Research Group (DURG) (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden. II. Hypertension. Eur J Clin Pharmacol 30: 521–525
Zusman RM (1986) Alternatives to traditional antihypertensive therapy. Hypertension 8: 837–842
Achutti A, Medeiros AMB (1985) Hipertensâo arterial no Rio Grande do Sul. Bol Saude 12: 2–72
Achutti A, Costa E, Fischman A, Bassanesi S, Klein C (1987) Epidemiological survey on arterial pressure supporting preventing health program ( Abstr ). Rev Med Chile 109: 435
Debert-Ribeiro MB, Ribeiro AB, Stabile Neto C, Chavess CC, Kater CE, lunes M, Saragoça MAS, et al. (1981) Hypertension and economic activities in Sâo Paulo, Brazil. Hypertension [Suppl 2] 3:11-233–11-237
Debert-Ribeiro MB, Ribeiro AB, Stabile Neto C, Ançâo MS, Saragoça MAS, Ramos OL, lunes M, et al. (1982) Prevalencia da hipertensâo na força de trabalho da Grande Sâo Paulo: Influencia de idade, sexo e grupo etnico. Rev Assoc Med Bras 28: 209–215
International Marketing Service (1981–1987) The pharmaceutical market of Brasil. International Marketing Service, ZUG
Ribeiro AB, Kohlmann O Jr, Marson O, Zanella MT, Ramos OL (1988) Hypertension: A major public health problem in Brazil. Drugs, (in press)
References
Aivazyan TA, Zaitsev VP, Yurenev AP (1987) Results of relaxation therapy application in essential hypertension. Kardiologiia 8: 34–36
Akuno T, Kondo K, Suzuki H, Saruta T (1980) Effects of prostaglandins E2, I2 and F2, arachidonic acid and undomethacin on pressor responses to norepinephrine in conscious rats. Prostaglandins 19: 855–864
Besseghir K (1985) Renal tubular action of prostaglandin E2 on water and electrolyte excretion in the nonanesthetized chicken. J Pharmacol Exp Ther 233: 823–829
Britov AN (1984) Control of arterial hypertension at the population level (in Russian). Klin Med (Mosk) 9: 43–49
Fabre L, Valloton MB (1983) Prostaglandines et pression arterielle. Schweiz Med Wochenschr 113: 1042–1049
Gifford RW, Tarazi RC (1978) Resistant hypertension: diagnosis and treatment. Ann Intern Med 88: 661–665
Kutsenko AL, Legkonogov AV (1987) Hypotensive effect of plasmapheresis in patients with severe symptomatic arterial hypertension due to renal disease (in Russian). Bull VKNC AMN USSR 1: 87–90
Lonigro AJ, Terragno NA, Maliket KU, et al. (1973) Differential inhibition by prostaglandins of the renal action of pressor stimuli. Prostaglandins 3: 595–606
McGiff JC (1981) Prostaglandins, prostacyclin and thromboxanes. Annu Rev Pharmacol Toxicol 21: 479–509
Nakano J, Chang A, Fisher R (1973) Effect of prostaglandins El5 E2, Ai, A2 and F2 on canine arterial blood flow, cerebrospinal fluid pressure and intraocular pressure. J Neurosurg 38: 32–39
Nekrasova AA, Dzhusipov AK, Shkhvatsabaya IK (1982) Use of prostaglandine E2 for the treatment of essential hypertension with high blood pressure levels (in Russian). Kardiologiia 9: 37–41
Nekrasova AA, Dzhusipov AK, Chernova NA, Uchitel IA, Akhmetov MA (1984) Change of endocrine renal function in patients with essential hypertension combined with stable hypertension under the effect of PGE infusions (in Russian). Ter Arkh 7: 89–93
Nekrasova AA, Suvorov YI, Chernova NA, et al. (1986) Water-salt metabolism in patients with stable essential hypertension and principles of diuretic treatment (in Russian). Kardiologiia 1: 27–34
Study Group of the All–Union Cooperative Program on Arterial Hypertension Prevention (AUCPAHP) (1986) Results of secondary prevention of arterial hypertension (in Russian). Bull VKNC AMN USSR 1: 56–62
Chang TS et al. (1978a) Hypotensive action of rhynchophylla alkaloids and rhynchophylline (in Chinese). Nat Med J China 58: 408–501
Chang TS et al. (1978b) Evaluation of the therapeutics effect of rhnchophylla alkaloid on hypertension by both Chinese traditional and western medical methods (in Chinese). Nat Med J China 58: 750–753.
Di SD et al. (1987) Study on risk factors for stroke in patients with hypertension (in Chinese). Acta Univ Med Secondae Shanghai 7: 339–342
Gao Y et al. (1965) Tetrandrine in hypertension, clinical observation and analysis of efficacy of treatment in 270 cases (in Chinese). Chin J Intern Med 13: 504–507
Gong LS et al. (1987b) Survey on present status of antihypertensive therapy in 22 clinics in Shanghai (in Chinese). Shanghai Med J 10: 97–98
Lu CQ et al. (1980) Preliminary report on general survey of hypertension of whole China in 1979 (in Chinese). Chin J Cardiol 8: 165–169
Mao HY et al. (1982) Rhomotoxin pharmacologic action in lowering blood pressure and slowing heart rate. Chin Med J 95: 311–318
Shen JQ, Wang LD (1983) Combined effect of hydrochlorothiazide and atenolol in antihypertensive therapy in 42 patients (in Chinese). Acta Pharmacol Sin 4: 254–258
Shen JQ et al. (1981) Atenolol, a new beta-adrenergic blocking agent in treatment of hypertension, therapeutic effect and hemodynamic changes (in Chinese). Chin J Cardiol 9: 94–98
Shen JQ et al. (1986) Therapeutic effects and echocardiography changes in a long term treatment of essential hypertension with western versus Chinese plus western drugs (in Chinese). Shanghai Med J 9: 501–505
Shen JQ et al. (1987) Observation of hemodynamic and echocardiography changes in the treatment of essential hypertension with Clonidine compound (in Chinese). N Drugs Clin Remedies 6: 74–77
Wang HM et al. (1986) Clinical observation on severe hypertension treated by intravenous labetalol (in Chinese). Chin J Cardiol 14: 28–30
Wang XM, Zhang WZ (1984) Collaborating action of Captopril combined with diuretics in the treatment of mild and moderate hypertension (in Chinese). N Drugs Clin Remedies 3: 150–152
Wang XM, Zhang WZ (1986) Clinical analysis of 48 cases of malignant hypertension (in Chinese). Acta Univ Med Secondae Shanghai 6: 362–363
Wu YK (1979) Epidemiology and community control of hypertension, stroke and coronary heart disease in China. Chin Med J 92: 665–670
Zhang WZ, Shen JQ (1982) Comparison of hemodynamic changes between atenolol and nifedipine in short term treatment of hypertension (in Chinese). N Drugs Clin Remedies 1: 97–100
Zhang WZ et al. (1987) Immediate hemodynamic effects in the treatment of hypertension with nitrendipine (in Chinese). N Drugs Clin Remedies 6: 78–79
Zhao LY et al. (1987) An observation of the clinical effects of indapamide on hypertension (in Chinese). Chin J Cardiol 15: 333–337
Zhu YJ et al. (1987) Systolic hypertension in the elderly (in Chinese). Chin J Geriatr 6: 246–247
References
Dahl LK (1960) Possible role of salt intake in the development of essential hypertension. In: Bock KD, Cottier PT (eds) Essential hypertension. Springer, Berlin Göttingen Heidelberg p 53
Isomura K (1987) An epidemiological study of the relationship between recent changes in the dietary habits of the young and old and cardiovascular disease (in Japanese). In: National Cardiovascular Center (ed) Annual Report of the Research on Cardiovascular Diseases 1986. National Cardiovascular Center, Suita p 550
Kagan A, Harris BB, Winkelstein W Jr, Johnson KG, Kato H, Syme SL, Rhoads GG, et al. (1974) Epidemiological studies of coronaty heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics. J Chronic Dis 27: 345–364
Ministry of Health and Welfare (1983a) Summary of national survey on circulatory disorders 1980. Report of national survey on circulatory disorders 1980. Japan Heart Foundation, Tokyo, p 17
Ministry of Health and Welfare (1983b) Summary of national survey on nutrition 1981 (in Japanese). Rinsho Eiyo 62: 38–42
Omae T (1985) Pathophysiology and outcome of hypertensive subjects (in Japanese). J Jpn Soc Intern Med 74: 401–405
Omae T, Ueda K, Kikumura T, Shikata T, Fujii I, Yanai T, Hasuo Y (1981) Cardiovascular deaths among hypertensive subjects of middle to old age: a long-term follow-up study in a Japanese community. In: Onesti G, Kim WE (eds) Hypertension in the young and the old. Grune and Stratton, New York, p 285
Omae T. Fukiyama K, Ishii M, Miura Y (1987) Current choice of antihypertensive drugs (in Japanese). Jpn J Hypertens 9: 81–97
Owada K (1985) International comparison of mortality, morbidity and risk factors of cardiovascular diseases (in Japanese). In: National Cardiovascular Center (ed) annual Report of the Research on Cardiovascular Diseases 1984. National Cardiovascular Center, Suita p 1
Ueda K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I, Fujii I, et al. (1988) Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke 19: 48–52
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lang, R. et al. (1990). Traditions of Antihypertensive Therapy in Different Countries. In: Ganten, D., Mulrow, P.J. (eds) Pharmacology of Antihypertensive Therapeutics. Handbook of Experimental Pharmacology, vol 93 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74209-5_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-74209-5_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74211-8
Online ISBN: 978-3-642-74209-5
eBook Packages: Springer Book Archive